Cargando…

A Comparison of COVID-19 Stigma and AIDS Stigma During the COVID-19 Pandemic: A Cross-Sectional Study in China

Objective: To understand the current situation of stigmatizing attitudes toward Coronavirus Disease 2019 (COVID-19) in China and compare it with acquired immunodeficiency syndrome (AIDS). Methods: Convenient sampling and vignette-based methods were used to recruit participants on WeChat. A demograph...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Manyun, Long, Jiang, Wang, Xuyi, Liao, Yanhui, Liu, Yueheng, Hao, Yuzhu, Wu, Qiuxia, Zhou, Yanan, Wang, Yingying, Wang, Yunfei, Wang, Qianjin, Ma, Yuejiao, Chen, Shubao, Liu, Tieqiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671734/
https://www.ncbi.nlm.nih.gov/pubmed/34925108
http://dx.doi.org/10.3389/fpsyt.2021.782501
_version_ 1784615202065481728
author Li, Manyun
Long, Jiang
Wang, Xuyi
Liao, Yanhui
Liu, Yueheng
Hao, Yuzhu
Wu, Qiuxia
Zhou, Yanan
Wang, Yingying
Wang, Yunfei
Wang, Qianjin
Ma, Yuejiao
Chen, Shubao
Liu, Tieqiao
author_facet Li, Manyun
Long, Jiang
Wang, Xuyi
Liao, Yanhui
Liu, Yueheng
Hao, Yuzhu
Wu, Qiuxia
Zhou, Yanan
Wang, Yingying
Wang, Yunfei
Wang, Qianjin
Ma, Yuejiao
Chen, Shubao
Liu, Tieqiao
author_sort Li, Manyun
collection PubMed
description Objective: To understand the current situation of stigmatizing attitudes toward Coronavirus Disease 2019 (COVID-19) in China and compare it with acquired immunodeficiency syndrome (AIDS). Methods: Convenient sampling and vignette-based methods were used to recruit participants on WeChat. A demographic form and adopted stigma scale were used to collect participants' demographic information and stigmatizing attitudes toward COVID-19 and AIDS. Results: A total of 13,994 questionnaires were included in this study. A high portion of participants tend to avoid contact with individuals affected with COVID-19 (74.3%) or AIDS (59.0%), as well as their family members (70.4% for COVID-19 and 47.9% for AIDS). About half of the participants agreed that affected persons could not only cause problems to their own family but also have adverse effects on others (59.6% and 55.6% for COVID-19, 56.9 and 47.0% for AIDS). The agreements with statements about perceived stigma were similar but slightly higher than those about personal stigma in both COVID-19 and AIDS. Participants' agreements with all statements regarding personal and perceived stigma attitudes between COVID-19 and AIDS were all statistically significant (p < 0.001). Participants obtained COVID-19-related information mainly from social media (91.3%) and newspaper or television (77.1%) during the epidemic, and 61.0% of them thought information from newspapers or television was the most reliable. Conclusion: Several similarities and differences of people's attitude toward COVID-19 and AIDS were found. Avoidance, blame, and secondary discrimination to diagnosed persons and their surrounding persons were the main representations of COVID-19-related stigma. Stigma of COVID-19 had less moral link but more public panic. Experience from HIV-related stigma reduction and prevention can be applied to reduce COVID-19-related stigma.
format Online
Article
Text
id pubmed-8671734
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86717342021-12-16 A Comparison of COVID-19 Stigma and AIDS Stigma During the COVID-19 Pandemic: A Cross-Sectional Study in China Li, Manyun Long, Jiang Wang, Xuyi Liao, Yanhui Liu, Yueheng Hao, Yuzhu Wu, Qiuxia Zhou, Yanan Wang, Yingying Wang, Yunfei Wang, Qianjin Ma, Yuejiao Chen, Shubao Liu, Tieqiao Front Psychiatry Psychiatry Objective: To understand the current situation of stigmatizing attitudes toward Coronavirus Disease 2019 (COVID-19) in China and compare it with acquired immunodeficiency syndrome (AIDS). Methods: Convenient sampling and vignette-based methods were used to recruit participants on WeChat. A demographic form and adopted stigma scale were used to collect participants' demographic information and stigmatizing attitudes toward COVID-19 and AIDS. Results: A total of 13,994 questionnaires were included in this study. A high portion of participants tend to avoid contact with individuals affected with COVID-19 (74.3%) or AIDS (59.0%), as well as their family members (70.4% for COVID-19 and 47.9% for AIDS). About half of the participants agreed that affected persons could not only cause problems to their own family but also have adverse effects on others (59.6% and 55.6% for COVID-19, 56.9 and 47.0% for AIDS). The agreements with statements about perceived stigma were similar but slightly higher than those about personal stigma in both COVID-19 and AIDS. Participants' agreements with all statements regarding personal and perceived stigma attitudes between COVID-19 and AIDS were all statistically significant (p < 0.001). Participants obtained COVID-19-related information mainly from social media (91.3%) and newspaper or television (77.1%) during the epidemic, and 61.0% of them thought information from newspapers or television was the most reliable. Conclusion: Several similarities and differences of people's attitude toward COVID-19 and AIDS were found. Avoidance, blame, and secondary discrimination to diagnosed persons and their surrounding persons were the main representations of COVID-19-related stigma. Stigma of COVID-19 had less moral link but more public panic. Experience from HIV-related stigma reduction and prevention can be applied to reduce COVID-19-related stigma. Frontiers Media S.A. 2021-12-01 /pmc/articles/PMC8671734/ /pubmed/34925108 http://dx.doi.org/10.3389/fpsyt.2021.782501 Text en Copyright © 2021 Li, Long, Wang, Liao, Liu, Hao, Wu, Zhou, Wang, Wang, Wang, Ma, Chen and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Li, Manyun
Long, Jiang
Wang, Xuyi
Liao, Yanhui
Liu, Yueheng
Hao, Yuzhu
Wu, Qiuxia
Zhou, Yanan
Wang, Yingying
Wang, Yunfei
Wang, Qianjin
Ma, Yuejiao
Chen, Shubao
Liu, Tieqiao
A Comparison of COVID-19 Stigma and AIDS Stigma During the COVID-19 Pandemic: A Cross-Sectional Study in China
title A Comparison of COVID-19 Stigma and AIDS Stigma During the COVID-19 Pandemic: A Cross-Sectional Study in China
title_full A Comparison of COVID-19 Stigma and AIDS Stigma During the COVID-19 Pandemic: A Cross-Sectional Study in China
title_fullStr A Comparison of COVID-19 Stigma and AIDS Stigma During the COVID-19 Pandemic: A Cross-Sectional Study in China
title_full_unstemmed A Comparison of COVID-19 Stigma and AIDS Stigma During the COVID-19 Pandemic: A Cross-Sectional Study in China
title_short A Comparison of COVID-19 Stigma and AIDS Stigma During the COVID-19 Pandemic: A Cross-Sectional Study in China
title_sort comparison of covid-19 stigma and aids stigma during the covid-19 pandemic: a cross-sectional study in china
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671734/
https://www.ncbi.nlm.nih.gov/pubmed/34925108
http://dx.doi.org/10.3389/fpsyt.2021.782501
work_keys_str_mv AT limanyun acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT longjiang acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT wangxuyi acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT liaoyanhui acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT liuyueheng acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT haoyuzhu acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT wuqiuxia acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT zhouyanan acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT wangyingying acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT wangyunfei acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT wangqianjin acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT mayuejiao acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT chenshubao acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT liutieqiao acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT limanyun comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT longjiang comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT wangxuyi comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT liaoyanhui comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT liuyueheng comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT haoyuzhu comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT wuqiuxia comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT zhouyanan comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT wangyingying comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT wangyunfei comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT wangqianjin comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT mayuejiao comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT chenshubao comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT liutieqiao comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina